Table 1.
Usage of antihypertensive substances in Swiss primary care offices. The percentage of patients receiving given substance(s) and the respective combination mode (individual or single-pill) is indicated as percentage of the total population. Note that only combinations prescribed to more than 50 patients are shown
Number of substances
|
1
|
2
|
3
|
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Combination mode | - | Individual | Single-pill | Individual | Single-pill | ||||||||||||||
ACE-inhibitor | + | + | + | + | + | + | |||||||||||||
Angiotensin receptor blocker | + | + | + | + | + | + | + | + | + | ||||||||||
Beta-blockers | + | + | + | + | + | + | |||||||||||||
Diuretic | + | + | + | + | + | + | + | + | + | + | |||||||||
Calcium-antagonist | + | + | + | + | + | + | |||||||||||||
Number of patients | 360 | 411 | 242 | 124 | 128 | 114 | 150 | 63 | 101 | 146 | 53 | 61 | 228 | 356 | 75 | 111 | 120 | 67 | 184 |
% of all patients (n=3,888) | 9.3 | 10.6 | 6.2 | 3.2 | 3.3 | 2.9 | 3.9 | 1.6 | 2.6 | 3.8 | 1.4 | 1.6 | 5.9 | 9.2 | 1.9 | 2.9 | 3.1 | 1.7 | 4.7 |
Abbreviation: ACE, angiotensin-converting enzyme.